Therapix Biosciences (TRPX) to Evaluate Opioid-Sparing Effects of Two Innovative Synthetic Cannabinoids in Preclinical Study Nov 10, 2017 08:33AM
Therapix Biosciences Plans Preclinical Study to Evaluate Opioid-Sparing Effects of Two Innovative Synthetic Cannabinoids Nov 10, 2017 08:30AM